Correlation Between Keros Therapeutics and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Keros Therapeutics and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Keros Therapeutics and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Keros Therapeutics and Biomarin Pharmaceutical, you can compare the effects of market volatilities on Keros Therapeutics and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Keros Therapeutics with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Keros Therapeutics and Biomarin Pharmaceutical.
Diversification Opportunities for Keros Therapeutics and Biomarin Pharmaceutical
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Keros and Biomarin is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Keros Therapeutics and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and Keros Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Keros Therapeutics are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of Keros Therapeutics i.e., Keros Therapeutics and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between Keros Therapeutics and Biomarin Pharmaceutical
Given the investment horizon of 90 days Keros Therapeutics is expected to generate 2.04 times more return on investment than Biomarin Pharmaceutical. However, Keros Therapeutics is 2.04 times more volatile than Biomarin Pharmaceutical. It trades about -0.09 of its potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.28 per unit of risk. If you would invest 5,799 in Keros Therapeutics on August 24, 2024 and sell it today you would lose (415.00) from holding Keros Therapeutics or give up 7.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Keros Therapeutics vs. Biomarin Pharmaceutical
Performance |
| Timeline |
| Keros Therapeutics |
| Biomarin Pharmaceutical |
Keros Therapeutics and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Keros Therapeutics and Biomarin Pharmaceutical
The main advantage of trading using opposite Keros Therapeutics and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Keros Therapeutics position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |